Log in to save to my catalogue

Post-marketing surveillance of anticancer drugs using natural language processing of electronic medi...

Post-marketing surveillance of anticancer drugs using natural language processing of electronic medi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a2244c2038eb49f781e599fd4847c3bf

Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records

About this item

Full title

Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records

Publisher

London: Nature Publishing Group UK

Journal title

NPJ digital medicine, 2024-11, Vol.7 (1), p.315-19, Article 315

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

This study demonstrates that adverse events (AEs) extracted using natural language processing (NLP) from clinical texts reflect the known frequencies of AEs associated with anticancer drugs. Using data from 44,502 cancer patients at a single hospital, we identified cases prescribed anticancer drugs (platinum, PLT; taxane, TAX; pyrimidine, PYA) and...

Alternative Titles

Full title

Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a2244c2038eb49f781e599fd4847c3bf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a2244c2038eb49f781e599fd4847c3bf

Other Identifiers

ISSN

2398-6352

E-ISSN

2398-6352

DOI

10.1038/s41746-024-01323-1

How to access this item